Excessively enhanced FGF23 concentrations of several hundred and up to several thousand pg/ml have been reported in both patients with end-stage renal disease and patients with end-stage heart failure [32, 33]. This evidence concerns the gene FGF23 and stage 5 chronic kidney disease.